This article appeared in the October 21, 2019 edition of the Monitor Daily.

Read 10/21 edition

A step forward in opioid lawsuits – but still no 'global settlement'

Keith Srakocic/AP
Drug evidence from opioid cases is shown at the police headquarters in Barberton, Ohio. The nation's three biggest drug distributors and a major drugmaker reached a $260 million settlement with two Ohio counties over the havoc wreaked by opioids, just hours before the first federal trial over the crisis was about to begin on Oct. 21, 2019.

Welcome to your Daily. Today we have the Kurdish view from Syria, the latest on Brexit in plain British, the equestrian statue repurposed, and paired items on a time of cultural revival in Mexico.

First, a court drama with national implications. Two Cleveland-area counties reached a last-minute settlement in a case against the nation’s leading pharmaceutical distributors, alleging illegal promotion of opioids by the companies.

For these two counties, both heavily affected by opioid abuse, the $260 million settlement means they will get much-needed money to help treat addiction and prevent further deaths. “It’s about rehabilitation and getting people straight,” said Michael C. O’Malley, Cuyahoga County prosecutor.

For the United States, this outcome postpones a larger reckoning. Some 2,600 lawsuits are pending by counties, cities, states, and tribes against corporations whose marketing and distribution of these pain-relief drugs may have played a significant role in a nationwide crisis. In the lead-up to this Ohio trial, for a time it looked possible that it could become the venue for a sweeping $48 billion settlement encompassing that legion of lawsuits. 

That possibility now awaits another case. By some measures even $48 billion would be a drop in the bucket. In a report this year, White House economists said the opioid crisis cost the U.S. economy $504 billion in 2015 alone. So, at stake is relief for people in more struggling communities like Cleveland. But as the Monitor highlighted this spring, it’s also about accountability: Many plaintiffs say courtroom trials could give a full airing to alleged illegal promotion efforts that put profits above responsibility with addictive drugs.

This article appeared in the October 21, 2019 edition of the Monitor Daily.

Read 10/21 edition
of stories this month > Get unlimited stories
You've read  of  free articles. Subscribe to continue.

Unlimited digital access $11/month.

Get unlimited Monitor journalism.